drugset / Trial / NCT01851759

Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction

NCT01851759

Phase 2 Unknown 288 enrolled Xijing Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Using placebo as control, The purpose of this study is to evaluate the efficacy and safety of methanesulfonic acid cinepazide injection to relieve disabled degree of acute cerebral infarction patients, and explore the best safe and effective dose as well as dose method.

Timeline

Start
2013-10
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject cinepazide Small molecule 125 mg Intravenous

Indications